%0 Journal Article %T Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations %A Yin, Lihui %A Xu-Monette, Zijun Y. %A Brock, Jay %A Li, Yong %A Young, Ken H. %J Annals of Translational Medicine %D 2018 %B 2018 %9 %! Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations %K %X Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma among adults, presenting heterogeneous biological and clinical features. The 2008 World Health Organization (WHO) classification of Epstein-Barr virus positive (EBV+) DLBCL of the elderly is limited to patients >50 years old without known immunodeficiency. The WHO classification was revised in 2016 to include immunocompetent patients of all ages and “EBV+ DLBCL of the elderly” has been replaced by “EBV+ DLBCL, not otherwise specified (EBV+ DLBCL, NOS)” (1). There are two key words differentiating EBV+ DLBCL, NOS from another lymphoma, “EBV+” and “immunocompetent”. %U https://atm.amegroups.org/article/view/19734 %V 6 %N 11 %P 236 %@ 2305-5847